GNCA: Genocea Biosciences Inc Stock Price Quote

2 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for Genocea Biosciences in the last twelve months. The consensus among Wall Street equities research analysts is that investors should “hold” GNCA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GNCA, but not buy additional shares or sell existing shares. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.52% per year.

Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company was incorporated in 2006 and is based in Cambridge, Massachusetts. On July 5, 2022, Genocea Biosciences, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S.

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Genocea Biosciences Inc. on Tuesday told investors it plans to shut down and lay off all remaining employees. The company said it gave notice to The Nasdaq Stock Market Inc. for its plans to voluntarily delist its common … Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. 2 Wall Street research analysts have issued twelve-month price objectives for Genocea Biosciences’ stock.

GNCAQ Genocea Biosciences, Inc.Stock Price & Overview

Notwithstanding the week’s strength, the sector has been one of the worst performers for the year-to-date period. According to analysts, Genocea Biosciences’s difference between a database and a data warehouse stock has a predicted upside of 650.00% based on their 12-month price targets. The technique has proven to be very useful for finding positive surprises.

The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. Sign-up to receive the latest news and ratings for Genocea Biosciences and its competitors with MarketBeat’s FREE daily newsletter. Investor HG Vora sees the real glitter in the company’s parts, and could have plans to boost shareholder value. Also, filings on Prevail Therapeutics, Universal Stainless & Alloy, Seres Therapeutics, Tivity Health, Chaparr… Analysts like Genocea Biosciences less than other Medical companies.

Barchart is committed to ensuring digital accessibility for individuals with disabilities. We are continuously working to improve our web experience, and encourage users to Contact Us for feedback and accommodation requests. GEN-011 shows consistent pattern of activity in first five heavily pre-treated, checkpoint-refractory patients with advanced solid tumors and…

Zacks Mobile App

Register now to watch these stocks streaming on the ADVFN Monitor. Genocea Biosciences Inc is a US-based biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies to address diseases with significant unmet needs. The company focuses on developing vaccines and immunotherapies for unmet needs through its AnTigen Lead Acquisition System, which is used to design vaccines and immunotherapies. Genocea operates its business through the single segment being Developing and Commercializing vaccines. The stock charts of NFLX, UAL and ULTA are prepped to get the new trading week started on a trade-worthy foot.

The Zacks Industry Rank assigns a rating to each of the 265 X Industries based on their average Zacks Rank. As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. 5 employees have rated Genocea Biosciences Chief Executive Officer William Clark on Glassdoor.com. William Clark has an approval rating of 82% among the company’s employees.

• 2 Wall Street research analysts have issued twelve-month price objectives for Genocea Biosciences’ stock.
• The gold catalyst we’ve waited forIf you thought the SVB meltdown was bad… watch out.
• A thumbnail of a daily chart is provided, with a link to open and customize a full-sized chart.
• If you have issues, please download one of the browsers listed here.

But there is ONE important step you should take today to make sure you come out the other side OK. If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan’s own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Genocea Biosciences Inc. shares plummeted late Monday after the tiny Cambridge, Mass.-based biotech said it was shifting its drug development focus and cutting staff by 40%.

Trading Services

Intraday data delayed at least 15 minutes or per exchange requirements. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed https://day-trading.info/ broker-dealer. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security.

Analysis of these related ETFs and how they are trading may provide insight to this commodity. Investors need to pay close attention to Genocea stock based on the movements in the options market lately. Live educational sessions using site features to explore today’s markets. Zacks Earnings ESP looks to find companies that have recently seen positive earnings estimate revision activity.

Companies with women executives can help you do better in the stock market

These returns cover a period from January 1, 1988 through February 6, 2023. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations.

Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only.

The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. The chart below shows how a company’s ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green. The company’s Stock price change every day as a result of market forces. If more people want to buy a stock than sell it , then the price moves up.

Conversely, if more people wanted to sell a stock than buy it, there would be greater supply than demand, and the price would fall. Real-time analyst ratings, insider transactions, earnings data, and more. Biotech stocks advanced in the week ended May 27, tracking the overall positive sentiment of the broader market.

Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and long-term periods. Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. After each calculation the program assigns a Buy, Sell, or Hold value with the study, depending on where the price lies in reference to the common interpretation of the study. For example, a price above its moving average is generally considered an upward trend or a buy. The chart below shows how a company’s share price and consensus price target have changed over time. The lighter blue line represents the stock’s consensus price target.

It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. The gold catalyst we’ve waited forIf you thought the SVB meltdown was bad… watch out. This signal proves that a recession is likely right around the corner.

There may be delays, omissions, or inaccuracies in the Information. The industry with the best average Zacks Rank would be considered the top industry , which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank would place in the bottom 1%. An industry with a larger percentage of Zacks Rank #1’s and #2’s will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4’s and #5’s. When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.

ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. © 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer. Sign-up to receive the latest news and ratings for GNCA and its competitors with MarketBeat’s FREE daily newsletter. Find exchange traded funds whose sector aligns with the same commodity grouping as the symbol you are viewing.

Please log in to your account or sign up in order to add this asset to your watchlist. Right-click on the chart to open the Interactive Chart menu. For US and Canadian Stocks, the Overview page includes key statistics on the stock’s fundamentals, with a link to see more. A thumbnail of a daily chart is provided, with a link to open and customize a full-sized chart. Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.